Forbes

Decibel Levels And Hearing Health: What To Know

Megan Gerhart, Au.D. received her doctorate of audiology from the University of Florida. She has experience helping pediatrics to geriatrics both in private practice and medical models of care. She ...
FiercePharma

Volume turns up on Decibel as hearing loss therapy protects patients in early-stage trial

A small data set but big improvement in the hearing loss brought on by chemotherapy was enough to send Decibel Therapeutics' shares soaring in premarket trading Tuesday. The Boston-based biotech has ...
FierceBiotech

Regeneron adds Decibel to gene therapy playlist, turning up volume on long-running hearing loss collaboration

Regeneron, listening to the call for more gene therapies, has added hearing loss specialist Decibel Therapeutics to its playlist in a deal valuing the biotech at $109 million at closing. Regeneron and ...
Seeking Alpha

DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss

Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer follow-up showed stability or continued ...
Nasdaq

Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin-Related ...

BOSTON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and ...
Nasdaq

Regeneron (REGN) to Buy Decibel, Gains on Hearing Loss Therapies

Regeneron Pharmaceuticals, Inc. REGN announced that it would acquire clinical-stage biotechnology company Decibel Therapeutics, Inc. DBTX for $213 million to expand its gene therapy programs for ...